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What is a pathogen?
A pathogen is usually defined as a microorganism that 
causes, or can cause, disease. We have defined a pathogen 
as a microbe that can cause damage in a host. However, 
this definition immediately raises the question of what it 
is  about  the  microorganism  that  enables  it  to  cause 
disease or damage; and this takes us to an ongoing debate 
that dates back to the late 19th century when the germ 
theory of disease was established. In the early days of the 
germ theory era many of the major pathogenic microbes 
were encapsulated or toxigenic bacteria, and this suggested 
that there were inherent differences between pathogenic 
and non-pathogenic microbes. However, even then it was 
obvious that neat classifications were problematic, for it 
was  known  that  a  microbe  could  be  attenuated  in  the 
laboratory, but virulence could be restored by passage in a 
host,  suggesting  that  the  same  microbe  could  exist  in 
pathogenic and non-pathogenic states.
Hang on - surely encapsulation and toxin 
production are inherent properties of the 
microorganism, so doesn’t the fact that these 
properties can be lost just mean pathogens can 
become non-pathogens?
Yes. But it’s more complicated than that. First of all, a 
factor or product that confers pathogenicity in a normal 
host  cannot  be  identified  for  many  microbes.  Second, 
properties conferring pathogenicity depend as much on 
the host as they do on the microorganism: encapsulated 
bacteria  are  pathogenic  because  they  have  a  polysac-
charide coat that prevents phagocytic cells from seeing 
them, and thereby avoid immediate elimination by the 
innate  immune  system  of  the  host.  Even  toxins  are 
damaging because they disrupt essential host functions. 
However, it was developments in the 20th century that 
clearly obliterated the hope of ever drawing a clear and 
unequivocal line of distinction between pathogens and 
non-pathogens. Beginning in the 1950s the introduction 
of  broad  spectrum  antimicrobial  agents,  immuno-
suppressive therapies, newer types of surgery, including 
organ transplantation and joint replacement, implantable 
devices  and  indwelling  catheters,  each  of  which  alters 
host-microbe  interactions,  turned  out  to  create 
conditions  in  which  the  host  became  vulnerable  to 
microbes  that  were  previously  considered  non-patho-
genic. As a result, it became apparent that many microbes 
previously considered non-pathogenic, or rarely patho-
genic,  such  as  Staphylococcus  epidermis  and  Candida 
albicans, could cause serious disease.
I can see how immunosuppression could make you 
vulnerable to the damage that microbes can cause, 
but antibiotics? Surgery?
Right. Antibiotics make people more vulnerable to microbe-
mediated damage because they alter the microbiota, or 
the normal microbial flora, and the balanced relationships 
between the microbes that reside in the mucosal niches 
in the body and the host structures that support these 
communities.  Surgery  can  have  the  same  effect  by 
removing  or  altering  normal  mucosal  and  cutaneous 
barriers  to  infection.  So  the  effects  of  antibiotics  and 
surgery enhance the pathogenicity of microbes that do 
not  ordinarily  cause  damage  or  disease  in  normal 
microbial communities, or intact mucosal and cutaneous 
surfaces, by making the host more susceptible to damage 
or invasion.
So pathogenicity can depend on whether some 
artificial situation enables the microorganism to 
infect the individual?
In part. Many microbes cause disease in some, but not all 
of those individuals who are infected with them. In fact, 
many microbes that cause disease are already present in 
the individual and the individual is thus already ‘infected’. 
This  is  exemplified  by  microbes  such  as  staphylococci 
and  Candida  spp.,  which  are  actually  present  in  most 
individuals,  but  only  cause  disease  in  some.  This  also 
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an individual is immune, either through prior infection 
or  through  vaccination,  as  immune  individuals  are 
recognized as being resistant to the capacity of a microbe 
to cause disease.
But surely in the case of immunity the pathogen 
is still a pathogen, it’s just that immunity prevents 
you from getting sick, right?
Not really. The question implies that the ability to cause 
damage or disease is an inherent microbial property, but in 
fact  these  characteristics  only  exist  in  the  context  of  a 
susceptible  host.  Therefore,  when  a  host  is  immune, 
pathogenicity  is  not  expressed.  What  is  important  to 
recognize is that pathogenicity and virulence are micro  bial 
properties that can only be expressed in a susceptible host.
What about the bacteria that normally inhabit 
our gut without causing disease - the so-called 
commensal bacteria: how does the immune system 
distinguish these bacteria from pathogens?
The  immune  system  does  not  distinguish  between 
pathogens  and  commensals.  In  fact,  the  question  of 
whether pathogenicity is a microbial trait and the ques  tion 
of  whether  hosts  distinguish  so-called  pathogens  from 
non-pathogens have the same answer: pathogenicity is an 
outcome  of  host-microbe  interaction  and  is  thus 
inextricably linked to characteristics of the host as well as 
those  of  the  microbe.  Rather  than  distinguishing  com-
mensals  from  pathogens/non-pathogens,  the  immune 
system  of  healthy  hosts  actually  depends  on  these 
microbes.  Commensals  (also  called  the  microbiota)  are 
acquired  by  infection  soon  after  birth,  after  which  they 
establish residence in mucosal niches where they replicate, 
and there is increasing evidence that the microbiota play a 
crucial role in the development of the immune system and 
that  the  immune  response  to  the  bacteria  in  mucosal 
niches  helps  maintain  barriers  to  invasion  on  surfaces 
exposed  to  potentially  harmful  microorganisms.  The 
commensal bacteria themselves do no harm, provided that 
the immune system and mucosal barriers remain normal 
and intact. The immune system provides a large variety of 
tools - cells and molecules - that recognize, react to and 
control microbial growth and invasion, often in a manner 
that does not result in host damage or disease, and when 
this  happens,  there  is  no  readout.  In  this  instance,  the 
immune system might be thought to have distinguished a 
pathogen  from  a  non-pathogen,  but  in  fact,  it  simply 
controls  microbial  growth  and/or  invasion  in  a  manner 
that does not translate into microbial pathogenicity.
In a situation where there is host damage or disease, 
there are two possibilities: either the immune system did 
not  contain  or  control  the  microbe  and  the  microbe 
caused host damage, or the host immune response to the 
microbe caused damage or disease, whether the microbe 
was controlled, or contained, or not. Thus, the immune 
system does not discriminate between microbes; it reacts 
to them, albeit differently depending on characteristics of 
the  host  and  characteristics  of  the  microbe,  with  the 
response defining an outcome that reflects the behavior 
of host and microbial factors.
So pathogenicity can be due to the immune response 
to the pathogen rather than the pathogen itself?
Absolutely.  The  obvious  case  is  where  the  immune 
response to some microbe is insufficient, and the microbe 
can replicate and disseminate throughout the host. In this 
instance, the lack of an immune response translates into 
the potential for pathogenicity (as mentioned above, even 
commensal  bacteria  can  be  pathogenic  if  the  immune 
system is impaired or the mucosal barrier is disrupted). 
This can occur because of the lack of a cellular or secreted 
factor that is needed to contain or control the microbe, 
and/or host or microbial factors that enable the microbe to 
evade the host response. An interesting paradox occurs in 
the  case  of  two  bacteria  that  produce  toxins  generally 
regarded as factors increasing the virulence of the microbe: 
staphylococci  that  produce  a  so-called  leukocidin,  and 
pneumococci  that  produce  a  toxin  called  pneumolysin. 
Because  these  toxins  also  activate  the  innate  immune 
response,  bacteria  that  do  not  produce  them  can 
sometimes  be  more  pathogenic  than  bacteria  that  do. 
Thus,  when  the  immune  response  to  a  microbe  is 
insufficient, microbial factors can cause damage, and when 
microbial factors fail to stimulate the immune system, the 
microbe can disseminate and cause disease.
At the other end of the spectrum, when the immune 
response  to  a  microbe  is  too  exuberant,  it  can  be  the 
immune  response  itself  that  is  responsible  for  the 
pathology. When damage occurs in this setting, it is most 
commonly  due  to  detrimental  inflammation  and  can 
occur whether the microbe is controlled or contained or 
not. Examples of this phenomenon include diseases like 
toxic shock syndrome, in which it is the potent activation 
of the immune response by a microbial component that 
does the damage. In these diseases, antimicrobial therapy 
is often unsuccessful because it does not reduce the host 
inflammatory  response.  In  fact,  new  directions  in  the 
treatment  of  infectious  diseases  that  are  marked  by 
exuberant inflammation increasingly involve the use of 
anti-inflammatory therapies.
You mentioned that the toxins produced by 
staphylococci and pneumococci increase their 
virulence - what is the difference between 
pathogenicity and virulence?
Although  these  terms  are  often  used  interchangeably, 
they have different meanings [6]. Pathogenicity is defined 
Pirofski and Casadevall BMC Biology 2012, 10:6 
http://www.biomedcentral.com/1741-7007/10/6
Page 2 of 3by  the  capacity  of  a  microbe  to  cause  damage  in  a 
(susceptible)  host.  Virulence  is  defined  as  the  relative 
capacity of a microbe to cause damage in a host. Although 
both pathogenicity and virulence can only be manifest in a 
susceptible host, pathogenicity is a discon  tinuous variable, 
that is, there is or is not pathogenicity, whereas virulence is 
a continuous variable, that is, it is defined by the amount of 
damage or disease that is manifest. Virulence is a relative 
term  for  there  is  no  absolute  measure  of  virulence  and 
virulence is always measured relative to another micro-
organism (for example, an attenuated strain, or a different 
species). Although they differ as delineated here, patho-
genicity  and  virulence  are  both  microbial  variables  that 
can only be expressed in a susceptible host, underscoring 
that each is dependent on host variables.
What is the difference between an opportunistic 
pathogen and any other kind of pathogen?
There is no difference between an opportunistic pathogen 
and any other kind of pathogen. Both are microbes and 
both have the potential to cause damage/disease in a host. 
The  definition  that  is  often  used  for  opportunistic 
pathogens is that these microbes cause disease in people 
with  impaired  immunity  but  not  in  normal  individuals. 
However,  this  definition  is  purely  operational:  the  same 
microbe - consider Candida albicans and Staphylococcus 
epidermidis - can cause disease in one individual but live 
harmlessly in others, which means that the same microbe 
would be called an opportunist in one individual and a 
commensal in another. Indeed, the identification of certain 
microbes as a cause of disease in certain hosts can unmask 
or be a sentinel for an underlying immunodeficiency.
However, although the absence of certain host factors 
or products can lead to an inability to control or contain 
certain microbes, the determinants of pathogenicity and 
virulence  for  these  microbes  depend  on  host  and 
microbial factors, as is the case for all microbes. In our 
view there are only microbes and hosts and the outcomes 
of  their  interactions,  which  include  commensalism, 
colonization,  latency  and  disease.  Hence,  attempts  to 
classify  microbes  as  pathogens,  non-pathogens,  oppor-
tunists, commensals and so forth are misguided because 
they attribute a property to the microbe that is instead a 
function of the host, the microbe, and their interaction.
Can the emergence of new pathogens be predicted?
Yes  and  no.  Pathogenicity  and  virulence  are  emergent 
properties, meaning that they cannot be predicted directly 
from the properties of the microorganism. The environ-
ment, an individual host or population of hosts and/or an 
individual microbe or population of microbes can change 
independently, or as a function of complex interactions, 
including those between environment and host, host and 
microbe, microbe and environment, and all three. Thus, 
microbial  pathogenicity  is  intrinsically  unpredictable. 
Host and microbial characteristics are subject to predic-
table  and  unpredictable  changes  prompted  by  known, 
unknown,  and  random  environmental,  immuno  logical, 
and  other  factors.  Thus,  as  it  is  an  outcome  of  host-
microbe  interaction  whereby  each  entity  is  subject  to 
independent and dependent changes at any point in time, 
pathogenicity is an emergent property.
So is prediction hopeless?
Not altogether. It is possible to test predictive hypotheses 
on  microbial  pathogenicity  in  model  systems  in  which 
microbe  and/or  host  can  be  held  constant.  That  said, 
however,  neither  the  complexity  nor  the  variability  or 
randomness  that  occurs  in  nature  occurs  or  can  be 
recapitulated in models systems. Thus, while predictions 
on how given (known) variables might affect the potential 
for a (new) microbe to be pathogenic in a given (known) 
population might be possible, such predictions are only 
possible  in  the  context  of  available  knowledge  and 
paradigms. This being the case, prediction of the emer-
gence  of  new  microbes  with  the  potential  for  patho-
genicity  will  always  be  subject  to  severe  limitations. 
Clearly, the continued acquisition of new knowledge and 
development of new scientific and intellectual platforms 
and paradigms will be important in bringing our models 
closer to reality.
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